Comparison of a Face Cream Plus a Laser Procedure and Face Cream Alone in Treatment of Excessive Face Hairs in Female
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Eflornithine Topical, Instense pulsed light, Eflornithine Topical.
- Who it may be relevant to
- Registry conditions: Hirsuitism. Basic parameters: 18 years — 45 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Pakistan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparison of Eflornithine Cream Combined With Intense Pulsed Light Versus Intense Pulsed Light Alone for Hirsutism in Women
Overview
The study compares the effects of a cream alone and a combined effect of cream and laser for the treatment of excessive facial hairs in women .
Detailed description
Hirsuitism refers to excessive terminal hairs in females, following a distribution pattern typically associated with male. It is associated with either increase response of hair follicles to androgen or either increase level of circulating androgens.The treatment options available are topical creams like eflornithine and laser treatments for hair removal. This study aims to conduct the comparison of a eflornithine cream and intense pulsed light laser versus eflornithine cream alone for the treatment of excessive facial hairs.
Interventions
- Drug Eflornithine Topical
Eflornithine cream will be applied to the face of group B female patients - Radiation Instense pulsed light
Intense pulse light will be applied to the face of patient of Group A on areas having increase hair. Patient will be called for a followup every month for next session. - Drug Eflornithine Topical
Eflornithine will be given to group A patient along with intense pulsed light and results will be compared to group B who recieved only Eflornithine cream
Primary outcome measures
- Efficacy of treatment [Time frame: 3 months]
Eligibility criteria
Inclusion criteria
Gender (Female) Age between 18-45 Years Women with hirsutism as mentioned in the operational definition
Exclusion criteria
Pregnant women Women with severe acne Women with immunodeficiency
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Pakistan · 3 centers
- Khyber Teaching Hospital — Peshawar
- Khyber Teaching Hospital — Peshawar
- Khyber Teachinng Hospital — Peshawar
Identifiers
NCT: NCT06976424 · 59/DME/KMC